Olix Pharmaceuticals, Inc.

Dayeon Yu

Sun Woo Hong

Hanna Lee

Ji Eom

Dong Ki Lee

Dong-Ki Lee

Tae Yeon Lee

Sae-Lo-Oom Lee

In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs or cell penetrating asiRNAs) that inhibit IL4R&#x3b1;, TRPA1, and/or F2RL1 expression and are therefore useful for treating atopic dermatitis or asthma.

Treatment of atopic dermatitis and asthma using RNA complexes that target IL4R&#x3b1;, TRPA1, or F2RL1

In certain aspects, provided herein are RNA complexes (e.g., asymmetric RNA complexes, such as asiRNAs or cell penetrating asiRNAs) that inhibit ANGPT2 and/or PDGFB expression and are therefore useful for treating angiogenesis-associated diseases, such as cancer, AMD, and DME.

Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB

Growing community of inventors

Seoul, South Korea

Dayeon Yu